[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337912-105":59,"doc-detail-337912-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","advances-in-bacterial-lysate-immunotherapy-for-infectious-diseases-and-cancer","Advances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer","","Review of antigenic fragments, pathogen-associated molecular patterns, and other immunostimulants in bacterial lysates assesses comparable roles in infectious disease and cancer therapy. In respiratory and urinary tract infections, bacterial lysate–driven immune activation helps identify and combat pathogens. Commercial lysates such as OM-85 and Ismigen show benefits in children and adults for respiratory conditions and COPD, while OM-89 and related products improve adult UTIs, with generally good tolerability. The review also discusses nonspecific immunomodulation and bacterial vaccine concepts as potential adjuvants or add-on cancer treatments.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-bacterial-lysate-immunotherapy-for-infectious-diseases-and-cancer/337912/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-bacterial-lysate-immunotherapy-for-infectious-diseases-and-cancer/337912.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of using bacterial lysates in infectious diseases and cancer treatment?","Question",{"text":113,"@type":114},"Bacterial lysates contain antigen-rich fragments and immunostimulants that can induce local and systemic immune responses. The review evaluates whether these functions are comparable across infectious diseases and cancer therapy.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which bacterial lysate products are mentioned for respiratory tract infections and COPD?",{"text":118,"@type":114},"The document lists OM-85, Ismigen, Lantigen B, and LW 50020 for respiratory infections and related conditions, and describes benefits such as reduced incidence, duration, exacerbations, and hospitalization in COPD.",{"name":120,"@type":111,"acceptedAnswer":121},"How are bacterial lysate-based therapies linked to cancer treatment in the review?",{"text":122,"@type":114},"The review describes nonspecific immunomodulation and cytokine-driven activation of adaptive immune responses. It argues that bacterial lysates may be investigated as vaccination adjuvants or add-on therapies for several cancers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337912,1790508550,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Wiley  \nJournal of Immunology Research Volume 2024, Article ID 4312908, 23 pages [https://doi.org/10.1155/2024/4312908](https://doi.org/10.1155/2024/4312908)  \nReview Article  \nAdvances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer  \nMd. Mijanur Rahman , 1,2 I. Darren Grice , 1,3 Glen C. Ulett , 1,2 and Ming Q. Wei 1,2  \n1School of Pharmacy and Medical Sciences, Grifﬁth University, Gold Coast 4222, QLD, Australia  \n2Menzies Health Institute Queensland, Grifﬁth University, Gold Coast 4222, QLD, Australia  \n3Institute for Glycomics, Grifﬁth University, Gold Coast 4222, QLD, Australia  \nCorrespondence should be addressed to Md. Mijanur Rahman; mijanur.rahman@grifﬁ[thuni.edu.au](thuni.edu.au)  \nReceived 2 January 2024; Revised 22 April 2024; Accepted 26 April 2024  \nAcademic Editor: Lele Zhu  \nCopyright © 2024 Md. Mijanur Rahman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nAntigenic cell fragments, pathogen-associated molecular patterns, and other immunostimulants in bacterial lysates or extracts may induce local and systemic immune responses in speciﬁc and nonspeciﬁc paradigms. Based on current knowledge, this review aimed to determine whether bacterial lysate has comparable functions in infectious diseases and cancer treatment. In infectious diseases, including respiratory and urinary tract infections, immune system activation by bacterial lysate can identify and combat pathogens.  \nCommercially available bacterial lysates, including OM-85, Ismigen, Lantigen B, and LW 50020, were effective in children and adults in treating respiratory tract infections, chronic obstructive pulmonary disease, rhinitis, and rhinosinusitis with varying degrees of success. Moreover, OM-89, Uromune, Urovac, Urivac, and ExPEC4V showed therapeutic beneﬁts in controlling urinary tract infections in adults, especially women. Bacterial lysate-based therapeutics are safe, well-tolerated, and have few side effects, making them a good alternative for infectious disease management. Furthermore, a nonspeciﬁc immunomodulation by bacterial lysates may stimulate innate immunity, beneﬁting cancer treatment.“Coley’s vaccine” has been used to treat sarcomas, carcinomas, lymphomas, melanomas, and myelomas with varying outcomes. Later, several similar bacterial lysate-based therapeutics have been developed to treat cancers, including bladder cancer, non-small cell lung cancer, and myeloma; among them, BCG for in situ bladder cancer is well-known. Proinﬂammatory cytokines, including IL-1, IL-6, IL-12, and TNF-α, may activate bacterial antigenspeciﬁc adaptive responses that could restore tumor antigen recognition and response by tumor-speciﬁc type 1 helper cells and cytotoxic T cells; therefore, bacterial lysates are worth investigating as a vaccination adjuvants or add-on therapies for several cancers.  \n1. Introduction  \nBacterial lysates (BLs) or extract-based preparations comprising antigen-rich cell fragments, pathogen-associated molecular patterns (PAMPs), and several other immunostimulants stimulate the immune system to recognize and combat infections [1, 2, 3, 4, 5] . It has been claimed that such preparations induce local and systemic immunomodulation, but clinical trials have found conﬂicting results. BLs are widely used therapeutically, though their immune system effects are only partially known [6] . Polyvalent mechanical bacterial lysates (PMBLs) and polyvalent chemical bacterial lysates (PCBLs) are two types of BLs used in clinical settings [7] . Patients with recurring respiratory tract infections (RTIs) and children with  \notitis media or nasopharyngitis beneﬁt more from PMBLs than PCBLs [8] . This may be because PMBLs contain comparatively less damaged and more chemically pure bacterial  \nantigens than PCBLs, increasing immunogenicity [9] .  \nSince the 19","cbCaigiRSnIwb4CT","https://ap.wps.com/l/cbCaigiRSnIwb4CT","pdf",843258,23,"English","# Introduction\n## Bacterial lysates: mechanisms and clinical background\n## Respiratory tract infections and commercial lysate products\n## Urinary tract infections and pediatric indications\n## Allergic and asthma-related outcomes","[{\"question\":\"What is the purpose of using bacterial lysates in infectious diseases and cancer treatment?\",\"answer\":\"Bacterial lysates contain antigen-rich fragments and immunostimulants that can induce local and systemic immune responses. The review evaluates whether these functions are comparable across infectious diseases and cancer therapy.\"},{\"question\":\"Which bacterial lysate products are mentioned for respiratory tract infections and COPD?\",\"answer\":\"The document lists OM-85, Ismigen, Lantigen B, and LW 50020 for respiratory infections and related conditions, and describes benefits such as reduced incidence, duration, exacerbations, and hospitalization in COPD.\"},{\"question\":\"How are bacterial lysate-based therapies linked to cancer treatment in the review?\",\"answer\":\"The review describes nonspecific immunomodulation and cytokine-driven activation of adaptive immune responses. It argues that bacterial lysates may be investigated as vaccination adjuvants or add-on therapies for several cancers.\"}]","Advances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer | PDF",1790021163,58,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1f7f855b18f499fdfde5d9a0dbe22ae.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29e307c80ea2c934dadd0236ccdae54f.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70a9021738e1fe8c00d96e2772eef6d0.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63d18b05cdd7c3f4ed9d1da9e9ba28d3.webp",980,1306]